Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation

Ádám I. Csincsi, Anne Kopp, Miklós Zöldi, Zsófia Bánlaki, Barbara Uzonyi, Mario Hebecker, Joseph J E Caesar, Matthew C. Pickering, Kenji Daigo, Takao Hamakubo, Susan M. Lea, Elena Goicoechea De Jorge, Mihály Józsi

Research output: Contribution to journalArticle

Abstract

The physiological roles of the factor H (FH)-related proteins are controversial and poorly understood. Based on genetic studies, FHrelated protein 5 (CFHR5) is implicated in glomerular diseases, such as atypical hemolytic uremic syndrome, dense deposit disease, and CFHR5 nephropathy. CFHR5 was also identified in glomerular immune deposits at the protein level. For CFHR5, weak complement regulatory activity and competition for C3b binding with the plasma complement inhibitor FH have been reported, but its function remains elusive. In this study, we identify pentraxin 3 (PTX3) as a novel ligand of CFHR5. Binding of native CFHR5 to PTX3 was detected in human plasma and the interaction was characterized using recombinant proteins. The binding of PTX3 to CFHR5 is of ∼2-fold higher affinity compared with that of FH. CFHR5 dose-dependently inhibited FH binding to PTX3 and also to the monomeric, denatured form of the short pentraxin C-reactive protein. Binding of PTX3 to CFHR5 resulted in increased C1q binding. Additionally, CFHR5 bound to extracellular matrix in vitro in a dose-dependent manner and competed with FH for binding. Altogether, CFHR5 reduced FH binding and its cofactor activity on pentraxins and the extracellular matrix, while at the same time allowed for enhanced C1q binding. Furthermore, CFHR5 allowed formation of the alternative pathway C3 convertase and supported complement activation. Thus, CFHR5 may locally enhance complement activation via interference with the complement-inhibiting function of FH, by enhancement of C1q binding, and by activating complement, thereby contributing to glomerular disease.

Original languageEnglish
Pages (from-to)4963-4973
Number of pages11
JournalJournal of Immunology
Volume194
Issue number10
DOIs
Publication statusPublished - May 15 2015

Fingerprint

Complement Factor H
Complement Activation
Extracellular Matrix
Proteins
Complement Inactivating Agents
Alternative Pathway Complement C3 Convertase
Membranoproliferative Glomerulonephritis
PTX3 protein
Recombinant Proteins
C-Reactive Protein
Ligands

ASJC Scopus subject areas

  • Immunology

Cite this

Csincsi, Á. I., Kopp, A., Zöldi, M., Bánlaki, Z., Uzonyi, B., Hebecker, M., ... Józsi, M. (2015). Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation. Journal of Immunology, 194(10), 4963-4973. https://doi.org/10.4049/jimmunol.1403121

Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation. / Csincsi, Ádám I.; Kopp, Anne; Zöldi, Miklós; Bánlaki, Zsófia; Uzonyi, Barbara; Hebecker, Mario; Caesar, Joseph J E; Pickering, Matthew C.; Daigo, Kenji; Hamakubo, Takao; Lea, Susan M.; De Jorge, Elena Goicoechea; Józsi, Mihály.

In: Journal of Immunology, Vol. 194, No. 10, 15.05.2015, p. 4963-4973.

Research output: Contribution to journalArticle

Csincsi, ÁI, Kopp, A, Zöldi, M, Bánlaki, Z, Uzonyi, B, Hebecker, M, Caesar, JJE, Pickering, MC, Daigo, K, Hamakubo, T, Lea, SM, De Jorge, EG & Józsi, M 2015, 'Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation', Journal of Immunology, vol. 194, no. 10, pp. 4963-4973. https://doi.org/10.4049/jimmunol.1403121
Csincsi, Ádám I. ; Kopp, Anne ; Zöldi, Miklós ; Bánlaki, Zsófia ; Uzonyi, Barbara ; Hebecker, Mario ; Caesar, Joseph J E ; Pickering, Matthew C. ; Daigo, Kenji ; Hamakubo, Takao ; Lea, Susan M. ; De Jorge, Elena Goicoechea ; Józsi, Mihály. / Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation. In: Journal of Immunology. 2015 ; Vol. 194, No. 10. pp. 4963-4973.
@article{dae9c77569f346e39b712a081286e72d,
title = "Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation",
abstract = "The physiological roles of the factor H (FH)-related proteins are controversial and poorly understood. Based on genetic studies, FHrelated protein 5 (CFHR5) is implicated in glomerular diseases, such as atypical hemolytic uremic syndrome, dense deposit disease, and CFHR5 nephropathy. CFHR5 was also identified in glomerular immune deposits at the protein level. For CFHR5, weak complement regulatory activity and competition for C3b binding with the plasma complement inhibitor FH have been reported, but its function remains elusive. In this study, we identify pentraxin 3 (PTX3) as a novel ligand of CFHR5. Binding of native CFHR5 to PTX3 was detected in human plasma and the interaction was characterized using recombinant proteins. The binding of PTX3 to CFHR5 is of ∼2-fold higher affinity compared with that of FH. CFHR5 dose-dependently inhibited FH binding to PTX3 and also to the monomeric, denatured form of the short pentraxin C-reactive protein. Binding of PTX3 to CFHR5 resulted in increased C1q binding. Additionally, CFHR5 bound to extracellular matrix in vitro in a dose-dependent manner and competed with FH for binding. Altogether, CFHR5 reduced FH binding and its cofactor activity on pentraxins and the extracellular matrix, while at the same time allowed for enhanced C1q binding. Furthermore, CFHR5 allowed formation of the alternative pathway C3 convertase and supported complement activation. Thus, CFHR5 may locally enhance complement activation via interference with the complement-inhibiting function of FH, by enhancement of C1q binding, and by activating complement, thereby contributing to glomerular disease.",
author = "Csincsi, {{\'A}d{\'a}m I.} and Anne Kopp and Mikl{\'o}s Z{\"o}ldi and Zs{\'o}fia B{\'a}nlaki and Barbara Uzonyi and Mario Hebecker and Caesar, {Joseph J E} and Pickering, {Matthew C.} and Kenji Daigo and Takao Hamakubo and Lea, {Susan M.} and {De Jorge}, {Elena Goicoechea} and Mih{\'a}ly J{\'o}zsi",
year = "2015",
month = "5",
day = "15",
doi = "10.4049/jimmunol.1403121",
language = "English",
volume = "194",
pages = "4963--4973",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation

AU - Csincsi, Ádám I.

AU - Kopp, Anne

AU - Zöldi, Miklós

AU - Bánlaki, Zsófia

AU - Uzonyi, Barbara

AU - Hebecker, Mario

AU - Caesar, Joseph J E

AU - Pickering, Matthew C.

AU - Daigo, Kenji

AU - Hamakubo, Takao

AU - Lea, Susan M.

AU - De Jorge, Elena Goicoechea

AU - Józsi, Mihály

PY - 2015/5/15

Y1 - 2015/5/15

N2 - The physiological roles of the factor H (FH)-related proteins are controversial and poorly understood. Based on genetic studies, FHrelated protein 5 (CFHR5) is implicated in glomerular diseases, such as atypical hemolytic uremic syndrome, dense deposit disease, and CFHR5 nephropathy. CFHR5 was also identified in glomerular immune deposits at the protein level. For CFHR5, weak complement regulatory activity and competition for C3b binding with the plasma complement inhibitor FH have been reported, but its function remains elusive. In this study, we identify pentraxin 3 (PTX3) as a novel ligand of CFHR5. Binding of native CFHR5 to PTX3 was detected in human plasma and the interaction was characterized using recombinant proteins. The binding of PTX3 to CFHR5 is of ∼2-fold higher affinity compared with that of FH. CFHR5 dose-dependently inhibited FH binding to PTX3 and also to the monomeric, denatured form of the short pentraxin C-reactive protein. Binding of PTX3 to CFHR5 resulted in increased C1q binding. Additionally, CFHR5 bound to extracellular matrix in vitro in a dose-dependent manner and competed with FH for binding. Altogether, CFHR5 reduced FH binding and its cofactor activity on pentraxins and the extracellular matrix, while at the same time allowed for enhanced C1q binding. Furthermore, CFHR5 allowed formation of the alternative pathway C3 convertase and supported complement activation. Thus, CFHR5 may locally enhance complement activation via interference with the complement-inhibiting function of FH, by enhancement of C1q binding, and by activating complement, thereby contributing to glomerular disease.

AB - The physiological roles of the factor H (FH)-related proteins are controversial and poorly understood. Based on genetic studies, FHrelated protein 5 (CFHR5) is implicated in glomerular diseases, such as atypical hemolytic uremic syndrome, dense deposit disease, and CFHR5 nephropathy. CFHR5 was also identified in glomerular immune deposits at the protein level. For CFHR5, weak complement regulatory activity and competition for C3b binding with the plasma complement inhibitor FH have been reported, but its function remains elusive. In this study, we identify pentraxin 3 (PTX3) as a novel ligand of CFHR5. Binding of native CFHR5 to PTX3 was detected in human plasma and the interaction was characterized using recombinant proteins. The binding of PTX3 to CFHR5 is of ∼2-fold higher affinity compared with that of FH. CFHR5 dose-dependently inhibited FH binding to PTX3 and also to the monomeric, denatured form of the short pentraxin C-reactive protein. Binding of PTX3 to CFHR5 resulted in increased C1q binding. Additionally, CFHR5 bound to extracellular matrix in vitro in a dose-dependent manner and competed with FH for binding. Altogether, CFHR5 reduced FH binding and its cofactor activity on pentraxins and the extracellular matrix, while at the same time allowed for enhanced C1q binding. Furthermore, CFHR5 allowed formation of the alternative pathway C3 convertase and supported complement activation. Thus, CFHR5 may locally enhance complement activation via interference with the complement-inhibiting function of FH, by enhancement of C1q binding, and by activating complement, thereby contributing to glomerular disease.

UR - http://www.scopus.com/inward/record.url?scp=84929095857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929095857&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1403121

DO - 10.4049/jimmunol.1403121

M3 - Article

C2 - 25855355

AN - SCOPUS:84929095857

VL - 194

SP - 4963

EP - 4973

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -